Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi-Qian Pan

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 28, 2023
Reply to G. Yu et alHao-Xiang Wu, Yi-Qian Pan, Zi-Xian Wang, et al.
Science Bulletin|April 1, 2023
Immunotherapy in gastrointestinal cancers: advances, challenges, and countermeasuresZi-Xian Wang, Yi-Qian Pan, Xuexin Li, et al.
Science Bulletin|February 6, 2024
Modulator of TMB-associated immune infiltration (MOTIF) predicts immunotherapy response and guides combination therapyZheng-Yu Qian, Yi-Qian Pan, Xue-Xin Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2022
Clinical Benefit of First-Line Programmed Death-1 Antibody Plus Chemotherapy in Low Programmed Cell Death Ligand 1-Expressing Esophageal Squamous Cell Carcinoma: A Post Hoc Analysis of JUPITER-06 and Meta-AnalysisHao-Xiang Wu, Yi-Qian Pan, Ye He, et al.
Clinical and Translational Medicine|December 1, 2023
Pan-cancer landscape of tumour endothelial cells pinpoints insulin receptor as a novel antiangiogenic target and predicts immunotherapy responseYongqiang Zheng, Yi-Qian Pan, Kun Liao, et al.
Molecular Cell|May 27, 2023
IL-1β-associated NNT acetylation orchestrates iron-sulfur cluster maintenance and cancer immunotherapy resistanceYi Han, Yan-Yu Zhang, Yi-Qian Pan, et al.
Science Bulletin|June 24, 2026
Pancancer pro-angiogenic atlas unravels tumor-educated pericyte-augmented anti-angiogenic resistanceYongqiang Zheng, Hui Sun, Zhe Fu, et al.
Nature Communications|October 23, 2023
The liver microenvironment orchestrates FGL1-mediated immune escape and progression of metastatic colorectal cancerJia-Jun Li, Jin-Hong Wang, Tian Tian, et al.
Gut|November 13, 2024
CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastasesYuanfang Li, Yongqiang Zheng, Jiaqian Huang, et al.
EMBO Molecular Medicine|November 14, 2024
Diagnosis and prognosis prediction of gastric cancer by high-performance serum lipidome fingerprintsZe-Rong Cai, Wen Wang, Di Chen, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 28, 2023
Reply to G. Yu et alHao-Xiang Wu, Yi-Qian Pan, Zi-Xian Wang, et al.
Science Bulletin|April 1, 2023
Immunotherapy in gastrointestinal cancers: advances, challenges, and countermeasuresZi-Xian Wang, Yi-Qian Pan, Xuexin Li, et al.
Science Bulletin|February 6, 2024
Modulator of TMB-associated immune infiltration (MOTIF) predicts immunotherapy response and guides combination therapyZheng-Yu Qian, Yi-Qian Pan, Xue-Xin Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2022
Clinical Benefit of First-Line Programmed Death-1 Antibody Plus Chemotherapy in Low Programmed Cell Death Ligand 1-Expressing Esophageal Squamous Cell Carcinoma: A Post Hoc Analysis of JUPITER-06 and Meta-AnalysisHao-Xiang Wu, Yi-Qian Pan, Ye He, et al.
Clinical and Translational Medicine|December 1, 2023
Pan-cancer landscape of tumour endothelial cells pinpoints insulin receptor as a novel antiangiogenic target and predicts immunotherapy responseYongqiang Zheng, Yi-Qian Pan, Kun Liao, et al.
Molecular Cell|May 27, 2023
IL-1β-associated NNT acetylation orchestrates iron-sulfur cluster maintenance and cancer immunotherapy resistanceYi Han, Yan-Yu Zhang, Yi-Qian Pan, et al.
Science Bulletin|June 24, 2026
Pancancer pro-angiogenic atlas unravels tumor-educated pericyte-augmented anti-angiogenic resistanceYongqiang Zheng, Hui Sun, Zhe Fu, et al.
Nature Communications|October 23, 2023
The liver microenvironment orchestrates FGL1-mediated immune escape and progression of metastatic colorectal cancerJia-Jun Li, Jin-Hong Wang, Tian Tian, et al.
Gut|November 13, 2024
CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastasesYuanfang Li, Yongqiang Zheng, Jiaqian Huang, et al.
EMBO Molecular Medicine|November 14, 2024
Diagnosis and prognosis prediction of gastric cancer by high-performance serum lipidome fingerprintsZe-Rong Cai, Wen Wang, Di Chen, et al.
Pageof 2